The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria
The aim of this retrospective analysis is to explore whether growth hormone (GH) pretreatment is beneficial for patients with poor ovarian reserve undertaking in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment. Poor ovarian reserve patients with anti-Mullerian hormone (AMH)...
Main Authors: | Mei-hong Cai, Lin-zhi Gao, Xiao-yan Liang, Cong Fang, Yao-qiu Wu, Xing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00775/full |
Similar Items
-
Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the POSEIDON Criteria
by: Fei Li, et al.
Published: (2021-04-01) -
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
by: Sandro C. Esteves, et al.
Published: (2018-08-01) -
Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve
by: San-Nung Chen, et al.
Published: (2019-11-01) -
Outcomes of High Initial Daily Doses of Gonadotropin in Patients With Poor Ovarian Reserve
by: Li-Ling Chou, et al.
Published: (2010-12-01) -
Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel’s back
by: Sabahat Rasool, et al.
Published: (2017-10-01)